HISTAI: a valuable dataset with a valuable lesson

IF 4.1 2区 医学 Q1 PATHOLOGY
Katherine J Hewitt, Nic G Reitsam, Sebastian Foersch, Ramona Erber, Qinghe Zeng, Jakob Nikolas Kather
{"title":"HISTAI: a valuable dataset with a valuable lesson","authors":"Katherine J Hewitt,&nbsp;Nic G Reitsam,&nbsp;Sebastian Foersch,&nbsp;Ramona Erber,&nbsp;Qinghe Zeng,&nbsp;Jakob Nikolas Kather","doi":"10.1002/2056-4538.70089","DOIUrl":null,"url":null,"abstract":"<p>The application of artificial intelligence in computational pathology depends on both robust algorithms and high-quality, clinically reliable data. Progress in this field has been limited by the scarcity of large, diverse, and well-validated whole slide image (WSI) datasets. To address this gap, HISTAI introduced an open-source resource comprising over 112,000 WSIs across multiple organ systems with associated clinical metadata. Here, we present a pathologist-led evaluation of label accuracy, metadata completeness, and dataset composition across 328 selected cases from this resource. Although HISTAI reports 47,279 cases, we identified only 44,564 unique cases after accounting for missing entries and duplicate records. Basic demographic information, including age and sex, was available for only 55% of cases. Dataset composition was uneven, with dermatopathology accounting for 47.1% of cases and gastrointestinal pathology for 24.0%; however, primary specialty was explicitly reported for only 39.6% of cases, obscuring this imbalance within the provided metadata. Notably, clinical ground truth is recorded in the Conclusion column. Concordance between the dataset's Conclusion and Diagnosis fields was observed in only 20.7% of cases, while 27.1% contained conflicting diagnoses. In a focused review of 198 cases, 30.3% were found to contain unclear or ambiguous diagnostic conclusions, including eight cases in which the diagnosis was incorrect. Assessment of molecular annotation revealed that only 18.9% of analyzed lung and colorectal cancer cases included molecular information. Furthermore, among adult-type diffuse gliomas, none of the 55 cases met current World Health Organisation Classification of Tumors of the Central Nervous System 5th Edition (WHO CNS5) diagnostic criteria, with <i>IDH</i> mutation status reported in only 15 cases. Together, these findings highlight substantial ambiguities in ground-truth labeling, incomplete molecular annotation, and limited documentation of dataset provenance and ethical oversight. While HISTAI represents a valuable open-source resource, its effective and responsible use requires careful clinical validation and close collaboration between computational researchers and pathologists.</p>","PeriodicalId":48612,"journal":{"name":"Journal of Pathology Clinical Research","volume":"12 3","pages":""},"PeriodicalIF":4.1000,"publicationDate":"2026-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13083215/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pathology Clinical Research","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/2056-4538.70089","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The application of artificial intelligence in computational pathology depends on both robust algorithms and high-quality, clinically reliable data. Progress in this field has been limited by the scarcity of large, diverse, and well-validated whole slide image (WSI) datasets. To address this gap, HISTAI introduced an open-source resource comprising over 112,000 WSIs across multiple organ systems with associated clinical metadata. Here, we present a pathologist-led evaluation of label accuracy, metadata completeness, and dataset composition across 328 selected cases from this resource. Although HISTAI reports 47,279 cases, we identified only 44,564 unique cases after accounting for missing entries and duplicate records. Basic demographic information, including age and sex, was available for only 55% of cases. Dataset composition was uneven, with dermatopathology accounting for 47.1% of cases and gastrointestinal pathology for 24.0%; however, primary specialty was explicitly reported for only 39.6% of cases, obscuring this imbalance within the provided metadata. Notably, clinical ground truth is recorded in the Conclusion column. Concordance between the dataset's Conclusion and Diagnosis fields was observed in only 20.7% of cases, while 27.1% contained conflicting diagnoses. In a focused review of 198 cases, 30.3% were found to contain unclear or ambiguous diagnostic conclusions, including eight cases in which the diagnosis was incorrect. Assessment of molecular annotation revealed that only 18.9% of analyzed lung and colorectal cancer cases included molecular information. Furthermore, among adult-type diffuse gliomas, none of the 55 cases met current World Health Organisation Classification of Tumors of the Central Nervous System 5th Edition (WHO CNS5) diagnostic criteria, with IDH mutation status reported in only 15 cases. Together, these findings highlight substantial ambiguities in ground-truth labeling, incomplete molecular annotation, and limited documentation of dataset provenance and ethical oversight. While HISTAI represents a valuable open-source resource, its effective and responsible use requires careful clinical validation and close collaboration between computational researchers and pathologists.

Abstract Image

HISTAI:一个有价值的数据集,一个有价值的教训。
人工智能在计算病理学中的应用依赖于稳健的算法和高质量的临床可靠数据。该领域的进展受到大型、多样化和经过良好验证的全幻灯片图像(WSI)数据集的缺乏的限制。为了解决这一差距,HISTAI引入了一个开源资源,包括超过112,000个跨多个器官系统的wsi,以及相关的临床元数据。在这里,我们提出了病理学家主导的标签准确性,元数据完整性和数据集组成的评估,从这个资源中选择了328个病例。尽管HISTAI报告了47,279例病例,但在考虑了缺失条目和重复记录后,我们仅确定了44,564例独特病例。包括年龄和性别在内的基本人口统计信息仅可用于55%的病例。数据集构成不均匀,皮肤病理占47.1%,胃肠病理占24.0%;然而,只有39.6%的病例明确报告了主要专科,这掩盖了所提供元数据中的这种不平衡。值得注意的是,临床事实记录在结论栏中。数据集的结论和诊断字段之间的一致性仅在20.7%的病例中观察到,而27.1%的病例包含冲突的诊断。在对198例病例的重点审查中,发现30.3%的诊断结论不明确或模棱两可,其中包括8例诊断不正确的病例。分子注释评估显示,仅18.9%的分析肺癌和结直肠癌病例包含分子信息。此外,在成人型弥漫性胶质瘤中,55例病例中没有一例符合当前世界卫生组织中枢神经系统肿瘤分类第5版(WHO CNS5)的诊断标准,只有15例报告了IDH突变状态。总之,这些发现突出了在基础事实标记、不完整的分子注释以及数据集来源和伦理监督的有限文档方面的实质性含糊性。虽然HISTAI代表了一种宝贵的开源资源,但它的有效和负责任的使用需要仔细的临床验证以及计算研究人员和病理学家之间的密切合作。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Pathology Clinical Research
Journal of Pathology Clinical Research Medicine-Pathology and Forensic Medicine
CiteScore
7.40
自引率
2.40%
发文量
47
审稿时长
20 weeks
期刊介绍: The Journal of Pathology: Clinical Research and The Journal of Pathology serve as translational bridges between basic biomedical science and clinical medicine with particular emphasis on, but not restricted to, tissue based studies. The focus of The Journal of Pathology: Clinical Research is the publication of studies that illuminate the clinical relevance of research in the broad area of the study of disease. Appropriately powered and validated studies with novel diagnostic, prognostic and predictive significance, and biomarker discover and validation, will be welcomed. Studies with a predominantly mechanistic basis will be more appropriate for the companion Journal of Pathology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书